Tuesday, September 4, 2012

Amarin's - Approved MARINE Patent claims


Read, understand and consent to the blog's DISCLAIMER here before proceeding to read the article

This is one big step towards protecting exclusivity of VASCEPA. The patent claims on TG & Apo-B reduction, LDL neutrality as well as non-HDL, Lp-Pla2 reduction. This patent is for the marine(500-2000mg/dl TG) indication.

Marine Patent claims-> Link

No comments:

Post a Comment